Some doctors improve cancer treatment. Very few change the fate of an entire disease. Dr. Lawrence Einhorn did.In this special episode, I sit down with Dr. Lawrence Einhorn, one of the true legends of oncology, my mentor and my friend. His cisplatin-based treatment helped transform testicular cancer from a once-devastating diagnosis into one of the greatest cure stories in modern medicine.We talk about why testicular cancer became such a transformative diagnosis, how cisplatin’s anti-cancer effect was discovered, what it was like to treat the first patients, and how he felt when young men who once had little chance began surviving.This conversation is not only about chemotherapy and clinical trials. It is also about courage, science, patients, love, hope, and the human side of cancer care.We also discuss what one of the most respected physicians in modern oncology thinks about the future of medicine, including the role of artificial intelligence.This is a conversation about one of the most important breakthroughs in cancer history — and the people behind it.Topics covered:Testicular cancerCisplatin chemotherapyThe history of cancer treatmentHow testicular cancer became curableThe first patients treated by Dr. EinhornCancer survivorshipThe human side of oncologyLove, hope, and treatmentArtificial intelligence in medicineSubscribe for more clear, evidence-based conversations about cancer, men’s health, and modern oncology.#DrLawrenceEinhorn #TesticularCancer #Cisplatin #CancerBreakthrough #IndianaUniversity #Oncology #CancerTreatment #CancerResearch #MensHealth #CancerSurvivorship #CancerPodcast #MedicalPodcast #AIinMedicine #CancerHistory #DrChovanec

For decades, men have been told that testosterone “feeds” prostate cancer.But is that actually what the modern data shows?In this video, I break down the real relationship between testosterone, TRT, PSA, and prostate cancer risk — including where the fear came from, why the old “fuel for the fire” model may be too simplistic, and what newer studies suggest about properly monitored testosterone therapy.We’ll cover:• Why prostate cancer is androgen-sensitive• The 1941 Huggins and Hodges study that shaped decades of thinking• Why advanced prostate cancer is not the same as low testosterone in otherwise evaluated men• The saturation model• What modern TRT safety data suggests• Why PSA monitoring still matters• When testosterone therapy requires cautionTestosterone is not a decision to make casually. But fear alone is not a medical strategy.The key is context, baseline evaluation, and careful monitoring.👉 Free Biopsy Checklist — 5 Questions to Ask Before Prostate Biopsy:https://drchovanec.kit.com/30968ddb5c📘 Optional Paid PSA Guide:A concise printable guide to help you understand PSA, MRI, biopsy decisions, and the diagnostic pathway.All core education is covered for free in my videos — this guide simply organizes it in one place.https://chovano.gumroad.com/l/luikhiSubscribe for calm, evidence-based prostate cancer education.—Dr. Michal ChovanecMedical OncologistHelping men make informed decisions about prostate cancer screening, diagnosis, and treatment.Medical disclaimer:This video is for educational purposes only and is not personal medical advice. Please discuss your individual situation with your doctor, especially before starting or stopping testosterone therapy.

👉 Free Biopsy Checklist (1 page): Don’t go to your appointment unprepared.Download and print: “Before Prostate Biopsy: 5 Essential Questions to Ask Your Urologist”https://drchovanec.kit.com/30968ddb5c📘 Optional PSA Guide (14 pages):If you want everything organised in one place, this printable guide walks you step-by-step through PSA interpretation, MRI decisions, and biopsy pathways.All information is covered for free in the videos — this is the structured version for clarity.https://chovano.gumroad.com/l/luikhiShould you get a PSA test?It sounds like a simple question.But the answer is one of the most controversial topics in modern medicine.Because the PSA test can save lives —but it can also lead to unnecessary biopsies, anxiety, and treatment for cancers that may never have caused harm.In this video, I break down the real data behind prostate cancer screening — including the four major clinical trials:• Göteborg Trial (44% relative reduction in mortality)• ERSPC 23-year follow-up (NEJM 2025)• PLCO Trial (U.S.)• CAP Trial (UK, 400,000+ men)You’ll understand:• What “lives saved” actually means in real numbers• Why the benefit is smaller than most people think• What overdiagnosis really is — and why it matters• Why many men are treated for cancers that would never harm them• Who should consider PSA screening — and who probably shouldn’tThis is not about fear.And it’s not about blind reassurance either.It’s about making an informed decision before you enter a pathway that’s hard to reverse.👨‍⚕️ About me:I’m Dr. Chovanec, medical oncologist and Associate Professor, trained at Indiana University under Dr. Lawrence Einhorn.On this channel, I break down cancer topics with clarity — so you can make calm, informed decisions.📌 If you found this helpful:• Subscribe for evidence-based cancer education• Share this with someone who is considering PSA testing• Comment your questions — I read every one⚠️ Disclaimer:This content is for educational purposes only and does not replace medical advice.